Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Net Margin (2020 - 2022)

Historic Net Margin for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2022 value amounting to 1673.5%.

  • SELLAS Life Sciences' Net Margin fell 16313400.0% to 1673.5% in Q1 2022 from the same period last year, while for Dec 2022 it was 4195.0%, marking a year-over-year decrease of 39226400.0%. This contributed to the annual value of 4130.1% for FY2022, which is 38577400.0% down from last year.
  • As of Q1 2022, SELLAS Life Sciences' Net Margin stood at 1673.5%, which was down 16313400.0% from 242.79% recorded in Q2 2021.
  • Over the past 5 years, SELLAS Life Sciences' Net Margin peaked at 42.16% during Q1 2021, and registered a low of 1673.5% during Q1 2022.
  • For the 3-year period, SELLAS Life Sciences' Net Margin averaged around 538.51%, with its median value being 219.18% (2020).
  • Within the past 5 years, the most significant YoY rise in SELLAS Life Sciences' Net Margin was -16313400bps (2022), while the steepest drop was -16313400bps (2022).
  • SELLAS Life Sciences' Net Margin (Quarter) stood at 195.58% in 2020, then dropped by -24bps to 242.79% in 2021, then plummeted by -589bps to 1673.5% in 2022.
  • Its last three reported values are 1673.5% in Q1 2022, 242.79% for Q2 2021, and 42.16% during Q1 2021.